Sensus Healthcare Statistics
Total Valuation
SRTS has a market cap or net worth of $104.23 million. The enterprise value is $85.96 million.
Important Dates
The next confirmed earnings date is Thursday, November 14, 2024, after market close.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SRTS has 16.39 million shares outstanding. The number of shares has decreased by -0.50% in one year.
| Shares Outstanding | 16.39M |
| Shares Change (YoY) | -0.50% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 19.01% |
| Owned by Institutions (%) | 20.57% |
| Float | 12.93M |
Valuation Ratios
The trailing PE ratio is 15.59 and the forward PE ratio is 16.74.
| PE Ratio | 15.59 |
| Forward PE | 16.74 |
| PS Ratio | 2.85 |
| Forward PS | 2.72 |
| PB Ratio | 1.97 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 12.94 |
| EV / Sales | 2.36 |
| EV / EBITDA | 9.80 |
| EV / EBIT | 10.05 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.63, with a Debt / Equity ratio of 0.01.
| Current Ratio | 11.63 |
| Quick Ratio | 7.96 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 13.44% and return on invested capital (ROIC) is 10.64%.
| Return on Equity (ROE) | 13.44% |
| Return on Assets (ROA) | 9.70% |
| Return on Capital (ROIC) | 10.64% |
| Revenue Per Employee | $1.04M |
| Profits Per Employee | $189,857 |
| Employee Count | 35 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 1.10 |
Taxes
In the past 12 months, SRTS has paid $2.88 million in taxes.
| Income Tax | 2.88M |
| Effective Tax Rate | 30.21% |
Stock Price Statistics
The stock price has increased by +189.09% in the last 52 weeks. The beta is 1.04, so SRTS's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | +189.09% |
| 50-Day Moving Average | 6.25 |
| 200-Day Moving Average | 5.13 |
| Relative Strength Index (RSI) | 48.02 |
| Average Volume (20 Days) | 83,197 |
Short Selling Information
The latest short interest is 585,779, so 3.57% of the outstanding shares have been sold short.
| Short Interest | 585,779 |
| Short Previous Month | 532,170 |
| Short % of Shares Out | 3.57% |
| Short % of Float | 4.53% |
| Short Ratio (days to cover) | 6.24 |
Income Statement
In the last 12 months, SRTS had revenue of $36.37 million and earned $6.65 million in profits. Earnings per share was $0.41.
| Revenue | 36.37M |
| Gross Profit | 21.90M |
| Operating Income | 8.55M |
| Pretax Income | 6.45M |
| Net Income | 6.65M |
| EBITDA | 8.77M |
| EBIT | 8.55M |
| Earnings Per Share (EPS) | $0.41 |
Full Income StatementBalance Sheet
The company has $18.97 million in cash and $698,000 in debt, giving a net cash position of $18.27 million or $1.12 per share.
| Cash & Cash Equivalents | 18.97M |
| Total Debt | 698,000 |
| Net Cash | 18.27M |
| Net Cash Per Share | $1.12 |
| Equity (Book Value) | 52.90M |
| Book Value Per Share | 3.23 |
| Working Capital | 49.79M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$847,000 and capital expenditures -$247,000, giving a free cash flow of -$1.09 million.
| Operating Cash Flow | -847,000 |
| Capital Expenditures | -247,000 |
| Free Cash Flow | -1.09M |
| FCF Per Share | -$0.07 |
Full Cash Flow StatementMargins
Gross margin is 60.23%, with operating and profit margins of 23.52% and 18.27%.
| Gross Margin | 60.23% |
| Operating Margin | 23.52% |
| Pretax Margin | 26.18% |
| Profit Margin | 18.27% |
| EBITDA Margin | 24.12% |
| EBIT Margin | 23.52% |
| FCF Margin | -14.42% |
Dividends & Yields
SRTS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.50% |
| Shareholder Yield | 0.50% |
| Earnings Yield | 6.38% |
| FCF Yield | -1.05% |
Analyst Forecast
The average price target for SRTS is $10.00, which is 57.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 57.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SRTS has an Altman Z-Score of 8.75 and a Piotroski F-Score of 4.
| Altman Z-Score | 8.75 |
| Piotroski F-Score | 4 |